Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetate
Marco Chiarini(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Luisa Imberti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Claudia Ghidini(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Federico Serana(University of Brescia), Ruggero Capra(Presidio Ospedaliero), Mariarosa Rottoli(University of Bergamo), Cinzia Cordioli(Ospedale Policlinico San Martino), Alessandra Sottini(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Camilla Zanotti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Roberto Bergamaschi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino)
Cited by 19
Related Papers
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
|Science Immunology|2021|638
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
|The Lancet|2002|552
Multiple sclerosis in childhood: clinical features of 149 cases
|Multiple Sclerosis Journal|1997|309
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
|Multiple Sclerosis Journal|2015|298